Leading brokers name 3 ASX shares to sell today

Blackmores Limited (ASX:BKL) shares are one of three that leading brokers have named as sells this week…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Monday I looked at three ASX shares have been given buy ratings by brokers this week.

Unfortunately, not all shares have been lucky enough to have been given the highly coveted buy rating this week.

The three shares listed below have all been given sell ratings. Here's why:

Blackmores Limited (ASX: BKL)

According to a note out of Morgan Stanley, its analysts have retained their underweight rating and $75.00 price target on this health supplements company's shares following the resignation of its chief executive officer on Tuesday. Its analysts are concerned that the change in the top job could heighten near-term earnings risk at a time when the company is struggling. The Blackmores share price is currently trading at $94.23, which means Morgan Stanley's price target implies potential downside of approximately 20%.

HUB24 Ltd (ASX: HUB)

A note out of the Macquarie equities desk reveals that its analysts have retained their underperform rating and cut the price target on this investment platform company's shares slightly to $9.90 following the release of its half year result. According to the note, the broker was disappointed with its first half performance and suspects that management delayed certain costs in the second half of FY 2018 and is paying the price for it now that market movements have turned negative. HUB24's share price is currently trading at $11.84.

InvoCare Limited (ASX: IVC)

Analysts at Deutsche Bank have retained their sell rating but increased the price target on this funerals company's shares to $11.70 after the release of its full year result. According to the note, the broker believes there are signs that competition remains fierce and consumers are favouring lower value funerals. Given that costs are rising, this is a concern for the broker. In addition to this, Deutsche is worried about long term structural headwinds facing the company. The InvoCare share price is currently changing hands at $14.60.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. The Motley Fool Australia has recommended InvoCare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

Three miners looking at a tablet.
Resources Shares

Own ASX mining shares? Experts say an upswing in commodity prices has begun

HSBC economists Paul Bloxham and Jamie Culling explain why global commodity prices are rising.

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brambles, Lifestyle Communities, Northern Star, and Select Harvests shares are sinking

These shares are having a tough session. But why?

Read more »

A young woman sits at her desk in deep contemplation with her hand to her chin while seriously considering information she is reading on her laptop
Share Market News

Will the Reserve Bank wait for the US Fed to cut interest rates first?

Here's when AMP thinks interest rates will be cut in the US, Australia, New Zealand, Canada and the Eurozone.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Gold bars on top of gold coins.
Gold

Is it too late to buy gold as an investment in 2024?

Can we still take advantage of gold at new record highs?

Read more »

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Mergers & Acquisitions

Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

Read more »